Soy isoflavones prevent obesity and hepatic steatosis by inhibiting mTORC1 via Akt phosphorylation, which results in the downregulation of SREBP1c and the upregulation of PPARα [54]. The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.